• Vytrus Biotech

  Participated · Equity · May 2024

  Vytrus Biotech develops, produces and commercializes high‑value cosmetic active ingredients derived from plant stem cells. The company sells globally through a network of distributors across Europe, the US, LATAM and Asia and operates from facilities in Terrassa (Barcelona) with a team of about 40 people. In Q1 2024 Vytrus reported a 32% year‑on‑year sales increase and its trailing 12‑month sales surpassed €4 million for the first time. Vytrus emphasizes sustainability—its active ingredients have saved more than 140,000 tonnes of water versus traditional botanical extracts and can reduce water use by up to 97% per kilo. The firm positions itself to become a multitechnology hub in cosmetics and plans to grow via both organic initiatives and acquisitions. Under its 2027 strategic plan Vytrus aims to triple sales to €12 million and quadruple EBITDA to €5 million, with a target mix of 60% revenue from current stem‑cell business and 40% from new technologies and acquisitions.

• Dolnai

  Participated · Equity · Sep 2020

  Dolnai develops an AI, deep‑tech and natural language processing platform that interprets the semantic ecosystem of digital advertising campaigns to predict opportunities and reduce costs and management time. The product targets large advertisers and marketing teams seeking improved ROI and operational efficiency. The company was founded by Manuel Arrufat (a long‑time Google Spain executive) and CTO Jose Antonio Torres, who has international Deep Tech research experience. Dolnai was selected for Lanzadera’s Growth program. Financially, the company closed its first investment round for €800,000. Future plans emphasize strengthening engineering and commercial teams to scale with market demand.

No current team members are available.